These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28279848)

  • 1. Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents.
    Němeček J; Sychra P; Macháček M; Benková M; Karabanovich G; Konečná K; Kavková V; Stolaříková J; Hrabálek A; Vávrová K; Soukup O; Roh J; Klimešová V
    Eur J Med Chem; 2017 Apr; 130():419-432. PubMed ID: 28279848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
    Karabanovich G; Němeček J; Valášková L; Carazo A; Konečná K; Stolaříková J; Hrabálek A; Pavliš O; Pávek P; Vávrová K; Roh J; Klimešová V
    Eur J Med Chem; 2017 Jan; 126():369-383. PubMed ID: 27907875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
    Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A
    Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of water-soluble 3,5-dinitrophenyl tetrazole and oxadiazole antitubercular agents.
    Roh J; Karabanovich G; Vlčková H; Carazo A; Němeček J; Sychra P; Valášková L; Pavliš O; Stolaříková J; Klimešová V; Vávrová K; Pávek P; Hrabálek A
    Bioorg Med Chem; 2017 Oct; 25(20):5468-5476. PubMed ID: 28835350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.
    Chauhan K; Sharma M; Trivedi P; Chaturvedi V; Chauhan PM
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4166-70. PubMed ID: 25127167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of (4-methoxyphenyl)-1H-tetrazol-5-amine regioisomers as a new class of selective antitubercular agents.
    Szulczyk D; Bielenica A; Głogowska A; Augustynowicz-Kopeć E; Dobrowolski M; Roszkowski P; Stępień K; Chrzanowska A; Struga M
    Eur J Med Chem; 2020 Jan; 186():111882. PubMed ID: 31753514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
    Adamec J; Waisser K; Kunes J; Kaustová J
    Arch Pharm (Weinheim); 2005 Aug; 338(8):385-9. PubMed ID: 16041837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase.
    Karabanovich G; Dušek J; Savková K; Pavliš O; Pávková I; Korábečný J; Kučera T; Kočová Vlčková H; Huszár S; Konyariková Z; Konečná K; Jand'ourek O; Stolaříková J; Korduláková J; Vávrová K; Pávek P; Klimešová V; Hrabálek A; Mikušová K; Roh J
    J Med Chem; 2019 Sep; 62(17):8115-8139. PubMed ID: 31393122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.
    Herzigová P; Klimesová V; Palát K; Kaustová J; Dahse HM; Möllmann U
    Arch Pharm (Weinheim); 2009 Jul; 342(7):394-404. PubMed ID: 19536781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
    Ganihigama DU; Sureram S; Sangher S; Hongmanee P; Aree T; Mahidol C; Ruchirawat S; Kittakoop P
    Eur J Med Chem; 2015 Jan; 89():1-12. PubMed ID: 25462220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular Activity.
    Veau D; Krykun S; Mori G; Orena BS; Pasca MR; Frongia C; Lobjois V; Chassaing S; Lherbet C; Baltas M
    ChemMedChem; 2016 May; 11(10):1078-89. PubMed ID: 27097919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel polycyclic 'cage'-1,2-diamines as potential anti-tuberculosis agents.
    Onajole OK; Coovadia Y; Kruger HG; Maguire GE; Pillay M; Govender T
    Eur J Med Chem; 2012 Aug; 54():1-9. PubMed ID: 22658084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
    Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M
    Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues.
    Gobis K; Foks H; Serocki M; Augustynowicz-Kopeć E; Napiórkowska A
    Eur J Med Chem; 2015 Jan; 89():13-20. PubMed ID: 25462221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,2,3,4,8,9,10,11-octahydrobenzo[j]phenanthridine-7,12-diones as new leads against Mycobacterium tuberculosis.
    Cappoen D; Claes P; Jacobs J; Anthonissen R; Mathys V; Verschaeve L; Huygen K; De Kimpe N
    J Med Chem; 2014 Apr; 57(7):2895-907. PubMed ID: 24611928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 5-methylpyrimidopyridone analogues as selective antimycobacterial agents.
    Wu Y; Cheung CY; Zhou Y; Wang Z; Tu Z; Cook GM; Lu X
    Bioorg Med Chem; 2021 Nov; 49():116426. PubMed ID: 34624820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.
    Ahmad Z; Sharma S; Khuller GK; Singh P; Faujdar J; Katoch VM
    Int J Antimicrob Agents; 2006 Dec; 28(6):543-4. PubMed ID: 17101262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
    Ventura C; Latino DA; Martins F
    Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.